Varun Medico Lab Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 3.38 M
as on 18-07-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.30 Cr
as on 18-07-2024
- Revenue -36.93%
(FY 2023)
- Profit -1503.98%
(FY 2023)
- Ebitda -8848.06%
(FY 2023)
- Net Worth -153.81%
(FY 2023)
- Total Assets -37.81%
(FY 2023)
About Varun Medico Lab
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.38 M.
The company has closed loans amounting to ₹1.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hemant Hajare and Nikhilesh Hajare serve as directors at the Company.
- CIN/LLPIN
U24239MH1996PTC099594
- Company No.
099594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Varun Medico Lab Private Limited offer?
Varun Medico Lab Private Limited offers a wide range of products and services, including Inflatable Toys and Preschool Toys, Kids Toys, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots.
Who are the key members and board of directors at Varun Medico Lab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Hajare  | Director | 27-Mar-2002 | Current |
| Nikhilesh Hajare | Director | 21-Apr-2012 | Current |
Financial Performance of Varun Medico Lab.
Varun Medico Lab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.93% decrease. The company also saw a substantial fall in profitability, with a 1503.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 153.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Varun Medico Lab?
In 2023, Varun Medico Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Dec 2003 | ₹1.30 Cr | Satisfied |
How Many Employees Work at Varun Medico Lab?
Unlock and access historical data on people associated with Varun Medico Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varun Medico Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varun Medico Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
